Patient Reported Outcomes After Radiation Therapy for Bone Metastases as a Function of Age: A Secondary Analysis of the NCIC CTG SC—Twenty-Three Randomized Trial
暂无分享,去创建一个
K. Ding | M. Brundage | A. Fairchild | R. Wong | P. Chabot | A. Dar | R. Meyer | Carolyn F. Wilson | G. Coulombe | E. Chow | A. Nabid | K. Dennis | C. DeAngelis | A. Mahmud | B. A. Wan | Liting Zhu | Shahida Ahmed | S. Chow | J. Kuk | Jackson S. Y. Wu
[1] Beicheng Sun,et al. Impact of age on the survival of patients with liver cancer: an analysis of 27,255 patients in the SEER database , 2015, Oncotarget.
[2] Mark T Lee,et al. Impact of advancing age on treatment and outcomes in anal cancer , 2014, Acta oncologica.
[3] Liying Zhang,et al. International field testing of the reliability and validity of the EORTC QLQ‐BM22 module to assess health‐related quality of life in patients with bone metastases , 2012, Cancer.
[4] K. Ding,et al. Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial. , 2015, The Lancet. Oncology.
[5] K. Ding,et al. Effect of Radiotherapy on Painful Bone Metastases: A Secondary Analysis of the NCIC Clinical Trials Group Symptom Control Trial SC.23 , 2017, JAMA oncology.
[6] Y. M. van der Linden,et al. A phase III international randomised trial comparing single with multiple fractions for re-irradiation of painful bone metastases: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) SC 20. , 2006, Clinical oncology (Royal College of Radiologists (Great Britain)).
[7] C. Cleeland,et al. Pain assessment: global use of the Brief Pain Inventory. , 1994, Annals of the Academy of Medicine, Singapore.
[8] B Rachet,et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data , 2011, Lancet.
[9] E. Inwald,et al. Screening-relevant age threshold of 70 years and older is a stronger determinant for the choice of adjuvant treatment in breast cancer patients than tumor biology , 2017, Breast Cancer Research and Treatment.
[10] P. Fayers,et al. The development of the EORTC QLQ-C15-PAL: a shortened questionnaire for cancer patients in palliative care. , 2006, European journal of cancer.
[11] C. Cleeland,et al. Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases , 1983, Pain.
[12] International consensus on palliative radiotherapy endpoints for future clinical trials in bone metastases. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[13] K. Ding,et al. Classification of painful bone metastases as mild, moderate, or severe using both EORTC QLQ-C15-PAL and EORTC QLQ-BM22 , 2016, Supportive Care in Cancer.
[14] Sheldon J. J. Kwok,et al. Radiotherapy for pain. , 2011, Clinical oncology (Royal College of Radiologists (Great Britain)).
[15] S. Tyldesley,et al. Factors affecting the use of palliative radiotherapy in Ontario. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Ahmedin Jemal,et al. Annual Report to the Nation on the status of cancer, 1973–1999, featuring implications of age and aging on U.S. cancer burden , 2002, Cancer.
[17] Ross Camidge,et al. The European Organisation for Research and Treatment of Cancer , 2002 .
[18] Howard S. Smith,et al. Painful osseous metastases. , 2011, Pain physician.
[19] Liying Zhang,et al. EORTC QLQ-C15-PAL quality of life scores in patients with advanced cancer referred for palliative radiotherapy , 2012, Supportive Care in Cancer.
[20] C. Beauchamp. Elderly patients with painful bone metastases should be offered palliative radiotherapy , 2011 .
[21] A. Bezjak,et al. The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22. , 2009, European journal of cancer.
[22] Kui-Sheng Chen,et al. Elevated expression of NEDD9 is associated with metastatic activity in gastric cancer , 2015, OncoTargets and therapy.
[23] C. Marijnen,et al. Effect of age on response to palliative radiotherapy and quality of life in patients with painful bone metastases. , 2014, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] H. Sørensen,et al. The impact of comorbidity on cancer survival: a review , 2013, Clinical epidemiology.
[25] G. Lyman,et al. What threshold for adjuvant therapy in older breast cancer patients? , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.